Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Gastric Cancer Management and Outcomes, Cancer Immunotherapy and Biomarkers, Luminescence Properties of Advanced Materials, and Solid State Laser Technologies.
Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study
Analysis of common treatment-related adverse events of donafenib and its correlation with efficacy: exploratory analysis of the ZGDH3 study
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Abstract CT078: First-line treatment with sintilimab (sin) vs placebo in combination with chemotherapy (chemo) in patients (pts) with unresectable gastric or gastroesophageal junction (G/GEJ) cancer: Final overall survival (OS) results from the randomized, phase III ORIENT-16 trial
A multicenter, phase 1 study of AB011, a recombinant humanized anti-CLDN18.2 monoclonal antibody, as monotherapy and combined with capecitabine and oxaliplatin (CAPOX) in patients with advanced solid tumors.
Abstract CT152: A multicenter Phase II study of savolitinib in patients with MET-amplified gastroesophogeal junction adenocarcinomas or gastric cancer
NLRP3 and Gut Microbiota Homeostasis: Progress in Research
A phase 1 trial of the PARP inhibitor fuzuloparib in combination with the anti-angiogenic apatinib in recurrent ovarian or triple-negative breast cancer.
Corrigendum: Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1) outcomes
Real-Time Monitoring Renal Impairment Due to Drug-Induced AKI and Diabetes-Caused CKD Using an NAG-Activatable NIR-II Nanoprobe
Imaging of ovarian cancers using enzyme activatable probes with second near-infrared window emission
<i>In Vivo</i> Imaging of Senescent Vascular Cells in Atherosclerotic Mice Using a β-Galactosidase-Activatable Nanoprobe
Fabrication and properties of Gd2O2S:Tb scintillation ceramics for the high-resolution neutron imaging
Preparation and optical properties of MgAl2O4-Ce:GdYAG composite ceramic phosphors for white LEDs
Fabrication and laser operation of Yb:Lu <sub>2</sub> O <sub>3</sub> transparent ceramics from co‐precipitated nano‐powders
Transparent Tb3Ga5O12 magneto-optical ceramics sintered from co-precipitated nano-powders calcined at different temperatures
Fabrication, microstructure, and optical properties of Yb:Y <sub>3</sub> ScAl <sub>4</sub> O <sub>12</sub> transparent ceramics with different doping levels
Influences of the Sc3+ content on the microstructure and optical properties of 10 at.% Yb:Y3ScxAl5-xO12 laser ceramics
A simple way to prepare Co:MgAl2O4 transparent ceramics for saturable absorber
Fabrication of Y2O3 transparent ceramics by hot isostatic pressing from precipitated nanopowders
Intestinal microbiota impact sepsis associated encephalopathy via the vagus nerve
Effects of regorafenib therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial.